India vs New Zealand 3rd Test Day 3 Highlights: Ajaz Patel's six-wicket haul helped New Zealand defeat India by 25 runs in the third Test on Sunday in Mumbai. This is the first time in the history ...
Copyright 2024 The Associated Press. All Rights Reserved. A 16-feet tall sculpture of a hand, dubbed Quasi, that loomed over Wellington, New Zealand on the roof of an ...
(RTTNews) - Sanofi announced that Beyfortus (nirsevimab ... Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of ...
New Zealand bowled out India for 245 in the second innings to wrap up a 113-run victory on day three of their second test in Pune on Saturday (October 26, 2024) and win the three-match series 2-0.
India crashed to a humiliating three-day home defeat by 113 runs in the second Test in Pune on Saturday as New Zealand became the first touring team to seal a series win in the country for 13 years.
Sanofi has begun 2013 on a positive note after announcing that it has 65 New Molecular Entity (NME) projects and vaccine candidates in clinical development. Of this 65, 17 are already in phase 3 ...
New Zealand have inflicted a first home Test series defeat on India since 2012 Second Test, Pune (day three of five) New Zealand 259 (Conway 76; Sundar 7-59) & 255 (Latham 86; Sundar 4-56 ...
India vs New Zealand Highlights, 2nd Test Day 2: New Zealand took command of the second Test against India at the MCA Stadium in Pune with a 301-run lead after dismissing the hosts for 156.
Among Sanofi’s rare disease drugs, new rare blood disorder drug Altuviiio, a once-weekly new class of factor VIII therapy for hemophilia A, recorded sales of €172 million in the third quarter ...
With less than two weeks until the election, a new Emerson College poll shows former President Donald Trump closing in on Vice President Kamala Harris in New Hampshire, where her lead has narrowed ...
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...
Sanofi and its partner AZ have moved quickly to ensure there isn’t a supply crunch repeat in 2024, recently adding a new filling line and shipping doses of the antibody early to get ahead of 202 ...